Abstract
Hepatocyte Growth Factor (HGF) is a gene primarily involved in the regulation of cell growth, motility and morphogenesis. Specifically, this growth factor acts upon cells of both epithelial and endothelial origin, in addition to haemopoietic stem cells. Typically, its function is achieved through a mechanism in which HGF binds to its corresponding membrane receptor, c-Met or MET, thus triggering the activation of Tyrosine Kinase signalling cascade. This cascade is collectively known as the process of “invasive growth” and gives rise to a sequence of biological responses essential to carry out its function. These responses facilitate cell growth and proliferation, which are essential for embryonic development and wound healing. In addition; the stimulatory effects of HGF on the processes of mitogenesis, cell motility and matrix invasion provide the cytokine with an imperative role in angiogenesis. HGF exerts a marked effect in cell growth, motility and morphogenesis. It demonstrates regulation of angiogenesis through the stimulation of mitogenesis, cell motility and matrix invasion. The presence of angiogenesis in tumour formation, growth and metastasis provide malignant tissue with sufficient nutrient supply to maintain its function.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Blumenschein GR Jr, Mills GB, Gonzalez-Angulo AM (2012) Targeting the hepatocyte growth factor-cMET axis in cancer therapy. J Clin Oncol 30(26):3287–3296. doi:10.1200/jco.2011.40.3774
Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF, Aaronson SA (1991) Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science (New York, NY) 251(4995):802–804
Burgess T, Coxon A, Meyer S, Sun J, Rex K, Tsuruda T, Chen Q, Ho SY, Li L, Kaufman S, McDorman K, Cattley RC, Sun J, Elliott G, Zhang K, Feng X, Jia XC, Green L, Radinsky R, Kendall R (2006) Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors. Cancer Res 66(3):1721–1729. doi:10.1158/0008-5472.can-05-3329
Ding S, Merkulova-Rainon T, Han ZC, Tobelem G (2003) HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro. Blood 101(12):4816–4822. doi:10.1182/blood-2002-06-1731
Goyal L, Muzumdar MD, Zhu AX (2013) Targeting the HGF/c-MET pathway in hepatocellular carcinoma. Clin Cancer Res 19(9):2310–2318. doi:10.1158/1078-0432.ccr-12-2791
Jiang WG, Martin TA, Matsumoto K, Nakamura T, Mansel RE (1999) Hepatocyte growth factor/scatter factor decreases the expression of occludin and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells. J Cell Physiol 181(2):319–329. doi:10.1002/(sici)1097-4652(199911)181:2<319::aid-jcp14>3.0.co;2-s
Koo BS, Kim JM, Seo ST, Yoon YH, Kwon KR, Kim SH, Kwon HW, Bae WJ, Lim YC (2014) Upregulation of HGF and c-MET is associated with subclinical central lymph node metastasis in papillary thyroid microcarcinoma. Ann Surg Oncol 21(7):2310–2317. doi:10.1245/s10434-014-3553-5
Lemmon MA, Schlessinger J (2010) Cell signaling by receptor tyrosine kinases. Cell 141(7):1117–1134. doi:10.1016/j.cell.2010.06.011
Mazzone M, Comoglio PM (2006) The Met pathway: master switch and drug target in cancer progression. FASEB J 20(10):1611–1621. doi:10.1096/fj.06-5947rev
Mazzone M, Basilico C, Cavassa S, Pennacchietti S, Risio M, Naldini L, Comoglio PM, Michieli P (2004) An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice. J Clin Invest 114(10):1418–1432. doi:10.1172/jci22235
Mizuno S, Nakamura T (2013) HGF-MET cascade, a key target for inhibiting cancer metastasis: the impact of NK4 discovery on cancer biology and therapeutics. Int J Mol Sci 14(1):888–919. doi:10.3390/ijms14010888
Nakamura T, Mizuno S (2010) The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc Jpn Acad Ser B Phys Biol Sci 86(6):588–610
Rosen EM, Lamszus K, Laterra J, Polverini PJ, Rubin JS, Goldberg ID (1997) HGF/SF in angiogenesis. Ciba Found Symp 212:215–226; discussion 227–219
Shang J, Deguchi K, Ohta Y, Liu N, Zhang X, Tian F, Yamashita T, Ikeda Y, Matsuura T, Funakoshi H, Nakamura T, Abe K (2011) Strong neurogenesis, angiogenesis, synaptogenesis, and antifibrosis of hepatocyte growth factor in rats brain after transient middle cerebral artery occlusion. J Neurosci Res 89(1):86–95. doi:10.1002/jnr.22524
Sugiura T, Kawaguchi Y, Soejima M, Katsumata Y, Gono T, Baba S, Kawamoto M, Murakawa Y, Yamanaka H, Hara M (2010) Increased HGF and c-Met in muscle tissues of polymyositis and dermatomyositis patients: beneficial roles of HGF in muscle regeneration. Clin Immunol (Orlando, Fla) 136(3):387–399. doi:10.1016/j.clim.2010.04.015
Trusolino L, Cavassa S, Angelini P, Ando M, Bertotti A, Comoglio PM, Boccaccio C (2000) HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity. FASEB J 14(11):1629–1640
Uchida D, Kawamata H, Omotehara F, Nakashiro K, Kimura-Yanagawa T, Hino S, Begum NM, Hoque MO, Yoshida H, Sato M, Fujimori T (2001) Role of HGF/c-met system in invasion and metastasis of oral squamous cell carcinoma cells in vitro and its clinical significance. Int J Cancer J Int du Cancer 93(4):489–496
Ueda T, Takeyama Y, Hori Y, Shinkai M, Takase K, Goshima M, Yamamoto M, Kuroda Y (2000) Hepatocyte growth factor increases in injured organs and functions as an organotrophic factor in rats with experimental acute pancreatitis. Pancreas 20(1):84–93
Wen Q, Zhou CY, Zhou MQ, Luo W, Ma L (2010) Differentiation of 5-azacytidine-induced bone marrow stromal stem cells transduced with hepatocyte growth factor gene. Nan fang yi ke da xue xue bao 30(7):1537–1540
Zanetta L, Marcus SG, Vasile J, Dobryansky M, Cohen H, Eng K, Shamamian P, Mignatti P (2000) Expression of Von Willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: a potential method for objective assessment of tumor angiogenesis. Int J Can J Int du Can 85(2):281–288
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Salajegheh, A. (2016). Hepatocyte Growth Factor. In: Angiogenesis in Health, Disease and Malignancy. Springer, Cham. https://doi.org/10.1007/978-3-319-28140-7_23
Download citation
DOI: https://doi.org/10.1007/978-3-319-28140-7_23
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28138-4
Online ISBN: 978-3-319-28140-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)